secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANGIODYNAMICS INC (ANGO)
CIK:        0001275187
Form:       8-K
Filed at:   2022-11-30T23:59:59+00:00
Accession:  0001140361-22-043590
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AngioDynamics guides Q2 cash ~$28-30M; results due Jan 5, 2023
--------------------------------------------------------------

- Expected cash at Nov 30, 2022 (Q2 FY2023 end): $28-30 million.
- Net cash increase of ~$3.5-5.5M from Q1 FY2023 end.
- Cash guidance excludes $4.2M CARES Act receivable.
- Q2 FY2023 earnings scheduled for release on or around Jan 5, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1275187/000114036122043590/0001140361-22-043590-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1275187/000114036122043590/brhc10044862_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-043590

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer